Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Seres Therapeutics Inc
About MCRB
Seres Therapeutics, Inc. is a clinical-stage company focused on improving patient outcomes in medically vulnerable populations through novel live biotherapeutics. It is developing SER-155, which has shown a significant reduction in bloodstream infections and related complications (as compared to placebo) in a Phase 1b clinical study in patients undergoing allo-HSCT and Fast Track designation to reduce the risk of infection and graft-versus-host disease in adults undergoing allo-HSCT. SER-155 and the Company’s other pipeline programs are designed to target multiple disease-relevant pathways. In addition to allo-HSCT, it intends to evaluate SER-155 and other cultivated live biotherapeutic candidates in other medically patient populations, including autologous-HSCT patients, cancer patients with neutropenia, CAR-T recipients, individuals with chronic liver disease, solid organ transplant recipients, as well as patients in the intensive care unit and long-term acute care facilities.
Find out what a historical investment in Seres Therapeutics Inc would be worth today using our MCRB stock calculator.
Market Capitalisation
$73.99M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
16.95K
High today
$7.90
Low today
$7.50
Open price
$7.82
52-week high
$29.98
52-week low
$6.53
Ready to start your investing journey with Stake?
Open an accountHow do I buy MCRB shares in Australia?
Buying MCRB shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Seres Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MCRB
What is the ticker symbol of Seres Therapeutics Inc?
The ticker symbol for Seres Therapeutics Inc is MCRB.
How much is one share of MCRB?
One share of MCRB is valued at $7.62 as of 16 May 2026.
What is the market capitalisation of Seres Therapeutics Inc MCRB?
As of 16 May 2026 Seres Therapeutics Inc has a market cap of $73.99M.
What is the 52-week high for Seres Therapeutics Inc stock?
The Seres Therapeutics Inc 52-week high stock price is $29.98.
What is the 52-week low for Seres Therapeutics Inc stock?
The Seres Therapeutics Inc 52-week low stock price is $6.53.
Can I buy MCRB shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MCRB shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MCRB on Stake
- Buy MCRB from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MCRB from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MCRB related stocks